Jacek Mokrosinski

Jacek Mokrosinski

Company: Novo Nordisk

Job title: Senior Scientist


Balancing GLP-1 Tolerability and Therapeutic Efficacy 8:30 am

Exploring discrepancies between efficacy and tolerability of GLP-1 mimetics Highlighting how better pharmacological profiling might help enhancing tolerability of incretin mimetics based on learnings from other targets and drug classes Discussing challenges and opportunities to optimize tolerability of GLP-1 therapeutic interventionsRead more

day: Conference Day Two

Panel Discussion: Exploring the Weight Independent Benefits of GLP-1 3:00 pm

Evaluating the impact of GLP-1s: are all observed benefits attributable to weight reduction or are other mechanisms in play? Considering how co-morbidities should be addressed from a clinical and commercial strategy perspective Clarifying uncertainties related to expanding into numerous new therapeutic areasRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.